BIOAGE LABS, INC. <BIOA.O>: UBS INITIATES COVERAGE WITH NEUTRAL RATING AND TARGET PRICE $8

Reuters2026/10/12 13:40

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

TIMBERCREEK FINANCIAL CORP <TF.TO>: TD COWEN CUTS TARGET PRICE TO C$5.5 FROM C$6

Reuters•2026/10/14 03:45

Venture Head Says Goldman and JPMorgan Are Becoming AI Stocks

BeInCrypto•2026/10/14 02:15

Can AAVE Price Reach $200 as V4 Deposits Top $300 Million?

Coinpedia•2026/10/13 23:12

BRIEF-Hub Cyber Security Appoints Richard Paolone And Joseph Tung To Its Board Of Directors

Reuters•2026/10/13 21:03